• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

隐匿却显著:肠梗阻背后的髓样癌

Silent Yet Striking: Medullary Carcinoma Behind an Intestinal Obstruction.

作者信息

Salimiaghdam Nasim, Mustafa Ahmed, Pokuaa Irene O, Hamidi Afshin, Chen Emily

机构信息

Internal Medicine Residency Program, Capital Health Regional Medical Center, Trenton, USA.

Internal Medicine, Capital Health Regional Medical Center, Trenton, USA.

出版信息

Cureus. 2025 Jun 24;17(6):e86669. doi: 10.7759/cureus.86669. eCollection 2025 Jun.

DOI:10.7759/cureus.86669
PMID:40709126
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12288939/
Abstract

Carcinoma of the ascending colon, especially the medullary type, is a rare and poorly differentiated form of colorectal cancer. This case report details a case of a 75-year-old woman with a background of cardiovascular issues, hypertension, and dementia who presented with complete large bowel obstruction and was found to have poorly differentiated carcinoma of the ascending colon with medullary features. The surgical approach involved an exploratory laparotomy followed by a right hemicolectomy. The pathological analysis confirmed a pT3N0M0, G3 stage II tumor, characterized by a loss of MLH1 and PMS2 protein expression, indicating microsatellite instability (MSI-H). Since there was no nodal involvement, adjuvant chemotherapy wasn't deemed necessary. The patient was encouraged to keep up with regular follow-ups, which would include monitoring carcinoembryonic antigen (CEA) levels, a complete metabolic panel (CMP), a complete blood count (CBC), and CT imaging every six months and annually. Although CEA is the most established tumor marker in colorectal cancer, it is still part of the follow-up plan, owing to its lack of sensitivity in the medullary subtype. In addition to this, the recommendation was for a surveillance colonoscopy every three years. This report sheds light on the case's pathological, clinical, and follow-up elements, emphasizing the need for personalized patient management.

摘要

升结肠癌,尤其是髓样型,是一种罕见且分化程度低的结直肠癌形式。本病例报告详细介绍了一名75岁女性患者,她有心血管问题、高血压和痴呆病史,因完全性大肠梗阻就诊,被发现患有具有髓样特征的低分化升结肠癌。手术方法包括剖腹探查术,随后进行右半结肠切除术。病理分析证实为pT3N0M0,G3 II期肿瘤,其特征是MLH1和PMS2蛋白表达缺失,表明微卫星不稳定(MSI-H)。由于没有淋巴结受累,不认为需要辅助化疗。鼓励患者定期随访,包括每六个月和每年监测癌胚抗原(CEA)水平、全套代谢检查(CMP)、全血细胞计数(CBC)和CT成像。尽管CEA是结直肠癌中最常用的肿瘤标志物,但由于其在髓样亚型中缺乏敏感性,它仍是随访计划的一部分。除此之外,建议每三年进行一次监测性结肠镜检查。本报告阐明了该病例的病理、临床和随访情况,强调了个性化患者管理的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5d/12288939/dbe8249f9f59/cureus-0017-00000086669-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5d/12288939/ebbd9ff1e69f/cureus-0017-00000086669-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5d/12288939/874477e54426/cureus-0017-00000086669-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5d/12288939/82be1e2021a5/cureus-0017-00000086669-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5d/12288939/f100a3aedebf/cureus-0017-00000086669-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5d/12288939/dbe8249f9f59/cureus-0017-00000086669-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5d/12288939/ebbd9ff1e69f/cureus-0017-00000086669-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5d/12288939/874477e54426/cureus-0017-00000086669-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5d/12288939/82be1e2021a5/cureus-0017-00000086669-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5d/12288939/f100a3aedebf/cureus-0017-00000086669-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5d/12288939/dbe8249f9f59/cureus-0017-00000086669-i05.jpg

相似文献

1
Silent Yet Striking: Medullary Carcinoma Behind an Intestinal Obstruction.隐匿却显著:肠梗阻背后的髓样癌
Cureus. 2025 Jun 24;17(6):e86669. doi: 10.7759/cureus.86669. eCollection 2025 Jun.
2
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
6
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.检测炎症性肠病患者结肠癌和/或发育异常的策略。
Cochrane Database Syst Rev. 2006 Apr 19(2):CD000279. doi: 10.1002/14651858.CD000279.pub3.
7
Lynch Syndrome林奇综合征
8
Characteristics of Mismatch Repair-Deficient Colon Cancer in Relation to Mismatch Repair Protein Loss, Hypermethylation Silencing, and Constitutional and Biallelic Somatic Mismatch Repair Gene Pathogenic Variants.错配修复缺陷型结直肠癌的特征与错配修复蛋白缺失、高甲基化沉默以及胚系和双等位基因体细胞错配修复基因致病性变异有关。
Dis Colon Rectum. 2023 Apr 1;66(4):549-558. doi: 10.1097/DCR.0000000000002452. Epub 2022 Jun 20.
9
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.检测炎症性肠病患者结肠癌和/或发育异常的策略。
Cochrane Database Syst Rev. 2004(2):CD000279. doi: 10.1002/14651858.CD000279.pub2.
10
Second malignancies in patients with deficient mismatch repair system/microsatellite instability-high colorectal cancer.错配修复缺陷系统/微卫星高度不稳定型结直肠癌患者的第二原发性恶性肿瘤
Therap Adv Gastroenterol. 2025 Jun 21;18:17562848251347375. doi: 10.1177/17562848251347375. eCollection 2025.

本文引用的文献

1
Microsatellite Instability and Metastatic Colorectal Cancer - A Clinical Perspective.微卫星不稳定性与转移性结直肠癌——临床视角
Front Oncol. 2022 Apr 28;12:888181. doi: 10.3389/fonc.2022.888181. eCollection 2022.
2
Immunotherapy in microsatellite instability metastatic colorectal cancer: Current status and future perspectives.微卫星不稳定转移性结直肠癌的免疫治疗:现状与未来展望。
J Clin Transl Res. 2021 Aug 4;7(4):511-522. eCollection 2021 Aug 26.
3
Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
结肠癌临床实践指南(2021 年第 2 版),NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2021 Mar 2;19(3):329-359. doi: 10.6004/jnccn.2021.0012.
4
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
5
Prognostic and Predictive Cross-Roads of Microsatellite Instability and Immune Response to Colon Cancer.微卫星不稳定性与结肠癌免疫反应的预后及预测交叉点
Int J Mol Sci. 2020 Dec 18;21(24):9680. doi: 10.3390/ijms21249680.
6
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.帕博利珠单抗治疗微卫星高度不稳定型晚期结直肠癌。
N Engl J Med. 2020 Dec 3;383(23):2207-2218. doi: 10.1056/NEJMoa2017699.
7
Microsatellite Instability and Survival in Stage II Colorectal Cancer: A Systematic Review and Meta-analysis.微卫星不稳定性与 II 期结直肠癌的生存:系统评价和荟萃分析。
Anticancer Res. 2019 Dec;39(12):6431-6441. doi: 10.21873/anticanres.13857.
8
Prognostic Impact of Tumor-Infiltrating Lymphocytes in Primary and Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis.原发性和转移性结直肠癌中肿瘤浸润淋巴细胞的预后影响:系统评价和荟萃分析。
Dis Colon Rectum. 2019 Apr;62(4):498-508. doi: 10.1097/DCR.0000000000001332.
9
NCCN Guidelines Insights: Colon Cancer, Version 2.2018.NCCN 指南解读:结肠癌,第 2.2018 版。
J Natl Compr Canc Netw. 2018 Apr;16(4):359-369. doi: 10.6004/jnccn.2018.0021.
10
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study.纳武利尤单抗治疗转移性DNA错配修复缺陷或微卫星高度不稳定结直肠癌患者(CheckMate 142):一项开放标签、多中心、2期研究。
Lancet Oncol. 2017 Sep;18(9):1182-1191. doi: 10.1016/S1470-2045(17)30422-9. Epub 2017 Jul 19.